Published on in Vol 23 , No 6 (2021) :June

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/23294, first published .
Acceptability of the Medication Event Reminder Monitor for Promoting Adherence to Multidrug-Resistant Tuberculosis Therapy in Two Indian Cities: Qualitative Study of Patients and Health Care Providers

Acceptability of the Medication Event Reminder Monitor for Promoting Adherence to Multidrug-Resistant Tuberculosis Therapy in Two Indian Cities: Qualitative Study of Patients and Health Care Providers

Acceptability of the Medication Event Reminder Monitor for Promoting Adherence to Multidrug-Resistant Tuberculosis Therapy in Two Indian Cities: Qualitative Study of Patients and Health Care Providers

Journals

  1. Fadahunsi K, Wark P, Mastellos N, Gallagher J, Majeed A, Car J. Clinical information quality of digital health technologies: protocol for an international eDelphi study. BMJ Open 2022;12(4):e057430 View
  2. Addo J, Pearce D, Metcalf M, Lundquist C, Thomas G, Barros-Aguirre D, Koh G, Strange M. Living with tuberculosis: a qualitative study of patients’ experiences with disease and treatment. BMC Public Health 2022;22(1) View
  3. Vaz C, Jose N, Tom J, Goodman G, Lee J, Padappayil R, Madathil M, O’Cleirigh C, Rodrigues R, Chai P. Formative acceptance of ingestible biosensors to measure adherence to TB medications. BMC Infectious Diseases 2022;22(1) View
  4. Fahrni M, Saman K, Alkhoshaiban A, Naimat F, Ramzan F, Isa K. Patient-reported outcome measures to detect intentional, mixed, or unintentional non-adherence to medication: a systematic review. BMJ Open 2022;12(9):e057868 View
  5. Manyazewal T, Woldeamanuel Y, Getinet T, Hoover A, Bobosha K, Fuad O, Getahun B, Fekadu A, Holland D, Marconi V. Patient-reported usability and satisfaction with electronic medication event reminder and monitor device for tuberculosis: a multicentre, randomised controlled trial. eClinicalMedicine 2023;56:101820 View
  6. Stadler J. Surveillance, Discipline and Care. Journal of Legal Anthropology 2021;5(1):58 View
  7. Saha S, Saxena D, Raval D, Halkarni N, Doshi R, Joshi M, Sridharan M, Sathwara J, Yasobant S, Shah H, Quazi Z, Rajsekar K, Chowdhury J. Tuberculosis Monitoring Encouragement Adherence Drive (TMEAD): Toward improving the adherence of the patients with drug-sensitive tuberculosis in Nashik, Maharashtra. Frontiers in Public Health 2022;10 View
  8. Garcia-Cremades M, Solans B, Strydom N, Vrijens B, Pillai G, Shaffer C, Thomas B, Savic R. Emerging Therapeutics, Technologies, and Drug Development Strategies to Address Patient Nonadherence and Improve Tuberculosis Treatment. Annual Review of Pharmacology and Toxicology 2022;62(1):197 View
  9. Mukora R, Maraba N, Orrell C, Jennings L, Naidoo P, Mbatha M, Velen K, Fielding K, Charalambous S, Chetty-Makkan C. Qualitative study exploring the feasibility of using medication monitors and a differentiated care approach to support adherence among people receiving TB treatment in South Africa. BMJ Open 2023;13(3):e065202 View